Praetorian Wealth Management’s TNF Pharmaceuticals, Inc. Common Stock TNFA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-67
| Closed | -$51.7K | – | 59 |
|
|
2023
Q4 | $51.7K | Hold |
67
| – | – | 0.02% | 57 |
|
|
2023
Q3 | $118K | Buy |
67
+59
| +738% | +$104K | 0.04% | 37 |
|
|
2023
Q2 | $37.5K | Hold |
8
| – | – | 0.01% | 36 |
|
|
2023
Q1 | $43K | Hold |
8
| – | – | 0.01% | 36 |
|
|
2022
Q4 | $28.8K | Buy |
8
+3
| +60% | +$10.8K | 0.01% | 54 |
|
|
2022
Q3 | $39K | Hold |
5
| – | – | 0.01% | 54 |
|
|
2022
Q2 | $32K | Buy |
+5
| New | +$32K | 0.01% | 39 |
|